EUVIMEDEUVIMED entdecken
Crossref

Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study

Allen B Richon, Merry Ambos Richon

Mathews Journal of Pharmaceutical Science · 2023

DOI: 10.30654/mjps.10021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathews Journal of Pharmaceutical Science, 2023. Verfasst von Allen B Richon und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Richon, A. B., & Richon, M. A. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews Journal of Pharmaceutical Science. https://doi.org/10.30654/mjps.10021

Vancouver

Richon AB, Richon MA. Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews Journal of Pharmaceutical Science. 2023. doi:10.30654/mjps.10021

BibTeX
@article{Richon2023,
  author = {Richon, Allen B and Richon, Merry Ambos},
  title = {Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study},
  journal = {Mathews Journal of Pharmaceutical Science},
  year = {2023},
  doi = {10.30654/mjps.10021}
}
Kostenlos starten →